Randomized, Double-blind, Placebo-controlled, Group-comparison, Dose-escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administration of Different Doses of Vardenafil (2 Dose Strengths) and BAY60-4552 (4 Dose Strengths) Given Once-daily (od) Over 14 Days in Patients With Erectile Dysfunction (ED).
Phase of Trial: Phase I
Latest Information Update: 29 Aug 2016
At a glance
- Drugs BAY 604552 (Primary) ; Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions
- Sponsors Bayer
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003991).
- 03 May 2010 New trial record